Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Fried, Eiko I
and
Nesse, Randolph M
2015.
Depression sum-scores don’t add up: why analyzing specific depression symptoms is essential.
BMC Medicine,
Vol. 13,
Issue. 1,
Fava, Giovanni A.
Tomba, Elena
and
Bech, Per
2017.
Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks.
Psychotherapy and Psychosomatics,
Vol. 86,
Issue. 3,
p.
134.
Fox, Molly
Sandman, Curt A.
Davis, Elysia Poggi
and
Glynn, Laura M.
2018.
A longitudinal study of women's depression symptom profiles during and after the postpartum phase.
Depression and Anxiety,
Vol. 35,
Issue. 4,
p.
292.
Fava, Maurizio
Freeman, Marlene P.
Flynn, Martina
Hoeppner, Bettina B.
Shelton, Richard
Iosifescu, Dan V.
Murrough, James W.
Mischoulon, David
Cusin, Cristina
Rapaport, Mark
Dunlop, Boadie W.
Trivedi, Madhukar H.
Jha, Manish
Sanacora, Gerard
Hermes, Gretchen
and
Papakostas, George I.
2018.
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
Brain Stimulation,
Vol. 11,
Issue. 1,
p.
75.
See, Chee Keong
Turnbull, Deborah
Ritson, Felix
Martin, Sean
Tully, Phillip
and
Wittert, Gary
2019.
Association of endogenous testosterone concentration with depression in men: a systematic review protocol.
JBI Database of Systematic Reviews and Implementation Reports,
Vol. 17,
Issue. 9,
p.
1894.
Sunderland, Matthew
Batterham, Philip
Calear, Alison
and
Carragher, Natacha
2019.
The Cambridge Handbook of Clinical Assessment and Diagnosis.
p.
263.
Kamiya, Makoto
Sabia, Helene D.
Marella, Julie
Fava, Maurizio
Nemeroff, Charles B.
Umeuchi, Hideo
Iijima, Michihiko
Chaki, Shigeyuki
and
Nishino, Izumi
2020.
Efficacy and safety of TS-121, a novel vasopressin V1B receptor antagonist, as adjunctive treatment for patients with major depressive disorder: A randomized, double-blind, placebo-controlled study.
Journal of Psychiatric Research,
Vol. 128,
Issue. ,
p.
43.
Fava, Maurizio
Freeman, Marlene P.
Flynn, Martina
Judge, Heidi
Hoeppner, Bettina B.
Cusin, Cristina
Ionescu, Dawn F.
Mathew, Sanjay J.
Chang, Lee C.
Iosifescu, Dan V.
Murrough, James
Debattista, Charles
Schatzberg, Alan F.
Trivedi, Madhukar H.
Jha, Manish K
Sanacora, Gerard
Wilkinson, Samuel T.
and
Papakostas, George I.
2020.
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Molecular Psychiatry,
Vol. 25,
Issue. 7,
p.
1592.
Papakostas, G. I.
Johe, K.
Hand, H.
Drouillard, A.
Russo, P.
Kay, G.
Kashambwa, R.
Hoeppner, B.
Flynn, M.
Yeung, A.
Martinson, M. A.
and
Fava, M.
2020.
A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.
Molecular Psychiatry,
Vol. 25,
Issue. 7,
p.
1569.
Santiago, J.
Akeman, E.
Kirlic, N.
Clausen, A. N.
Cosgrove, K. T.
McDermott, T. J.
Mathis, B.
Paulus, M.
Craske, M. G.
Abelson, J.
Martell, C.
Wolitzky-Taylor, K.
Bodurka, J.
Thompson, W. K.
and
Aupperle, Robin L.
2020.
Protocol for a randomized controlled trial examining multilevel prediction of response to behavioral activation and exposure-based therapy for generalized anxiety disorder.
Trials,
Vol. 21,
Issue. 1,
Maj, Mario
Stein, Dan J.
Parker, Gordon
Zimmerman, Mark
Fava, Giovanni A.
De Hert, Marc
Demyttenaere, Koen
McIntyre, Roger S.
Widiger, Thomas
and
Wittchen, Hans‐Ulrich
2020.
The clinical characterization of the adult patient with depression aimed at personalization of management.
World Psychiatry,
Vol. 19,
Issue. 3,
p.
269.
Duman, Tuğçe
Akyüz, Enes
Bulut, Huri
Koçyiğit, Abdurrahim
Tülek, Ahmet
Karataş, Ersin
and
Kırpınar, İsmet
2021.
Investigation of Diagnostic Proteins by 2D Electrophoresis in Major Depression Model Induced by Forced Swim Test in Rats.
Protein & Peptide Letters,
Vol. 28,
Issue. 2,
p.
195.
Geijer, Jonas
Baigi, Amir
and
Aiff, Harald
2021.
Inter-rater reliability among psychiatrists when assessing depression according to the Montgomery–Åsberg Depression Rating Scale.
Nordic Journal of Psychiatry,
Vol. 75,
Issue. 8,
p.
607.
Palotai, Miklos
Wallack, Max
Kujbus, Gergo
Dalnoki, Adam
and
Guttmann, Charles
2021.
Usability of a Mobile App for Real-Time Assessment of Fatigue and Related Symptoms in Patients With Multiple Sclerosis: Observational Study.
JMIR mHealth and uHealth,
Vol. 9,
Issue. 4,
p.
e19564.
Martin-Key, Nayra A
Mirea, Dan-Mircea
Olmert, Tony
Cooper, Jason
Han, Sung Yeon Sarah
Barton-Owen, Giles
Farrag, Lynn
Bell, Emily
Eljasz, Pawel
Cowell, Daniel
Tomasik, Jakub
and
Bahn, Sabine
2021.
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation Study.
JMIR Formative Research,
Vol. 5,
Issue. 10,
p.
e27908.
Sforzini, Luca
Worrell, Courtney
Kose, Melisa
Anderson, Ian M.
Aouizerate, Bruno
Arolt, Volker
Bauer, Michael
Baune, Bernhard T.
Blier, Pierre
Cleare, Anthony J.
Cowen, Philip J.
Dinan, Timothy G.
Fagiolini, Andrea
Ferrier, I. Nicol
Hegerl, Ulrich
Krystal, Andrew D.
Leboyer, Marion
McAllister-Williams, R. Hamish
McIntyre, Roger S.
Meyer-Lindenberg, Andreas
Miller, Andrew H.
Nemeroff, Charles B.
Normann, Claus
Nutt, David
Pallanti, Stefano
Pani, Luca
Penninx, Brenda W. J. H.
Schatzberg, Alan F.
Shelton, Richard C.
Yatham, Lakshmi N.
Young, Allan H.
Zahn, Roland
Aislaitner, Georgios
Butlen-Ducuing, Florence
Fletcher, Christine
Haberkamp, Marion
Laughren, Thomas
Mäntylä, Fanni-Laura
Schruers, Koen
Thomson, Andrew
Arteaga-Henríquez, Gara
Benedetti, Francesco
Cash-Gibson, Lucinda
Chae, Woo Ri
De Smedt, Heidi
Gold, Stefan M.
Hoogendijk, Witte J. G.
Mondragón, Valeria Jordán
Maron, Eduard
Martynowicz, Jadwiga
Melloni, Elisa
Otte, Christian
Perez-Fuentes, Gabriela
Poletti, Sara
Schmidt, Mark E.
van de Ketterij, Edwin
Woo, Katherine
Flossbach, Yanina
Ramos-Quiroga, J. Antoni
Savitz, Adam J.
and
Pariante, Carmine M.
2022.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Molecular Psychiatry,
Vol. 27,
Issue. 3,
p.
1286.
Lambrichts, Simon
Vansteelandt, Kristof
Hebbrecht, Kaat
Wagenmakers, Margot J.
Oudega, Mardien L.
Obbels, Jasmien
van Exel, Eric
Dols, Annemiek
Bouckaert, Filip
Schrijvers, Didier
Verwijk, Esmée
and
Sienaert, Pascal
2022.
Which residual symptoms predict relapse after successful electroconvulsive therapy for late-life depression?.
Journal of Psychiatric Research,
Vol. 154,
Issue. ,
p.
111.
Fava, Maurizio
Stahl, Stephen
Pani, Luca
De Martin, Sara
Pappagallo, Marco
Guidetti, Clotilde
Alimonti, Andrea
Bettini, Ezio
Mangano, Richard M.
Wessel, Thomas
de Somer, Marc
Caron, Judy
Vitolo, Ottavio V.
DiGuglielmo, Gina R.
Gilbert, Adam
Mehta, Hiren
Kearney, Morgan
Mattarei, Andrea
Gentilucci, Marco
Folli, Franco
Traversa, Sergio
Inturrisi, Charles E.
and
Manfredi, Paolo L.
2022.
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.
American Journal of Psychiatry,
Vol. 179,
Issue. 2,
p.
122.
Grassi, Giacomo
Moradei, Corinna
Cecchelli, Chiara
and
van Ameringen, Michael
2023.
Who really hoards? Hoarding symptoms in adults with attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD) and healthy controls.
Journal of Psychiatric Research,
Vol. 166,
Issue. ,
p.
74.
Fava, Maurizio
2024.
How should we design future mechanistic and/or efficacy clinical trials?.
Neuropsychopharmacology,
Vol. 49,
Issue. 1,
p.
197.